Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Labauge

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Brain : a Journal of Neurology|September 26, 2013
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcificationGaël Nicolas, Cyril Pottier, Camille Charbonnier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Journal of Neurology|April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesionsXavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
Human Mutation|August 17, 2016
Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited AtaxiasCecilia Marelli, Claire Guissart, Cecile Hubsch, et al.
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology|January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyLaetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Neurology|April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR studyAlvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Brain : a Journal of Neurology|June 24, 2020
Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disabilityAnne Kerbrat, Charley Gros, Atef Badji, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Brain : a Journal of Neurology|September 26, 2013
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcificationGaël Nicolas, Cyril Pottier, Camille Charbonnier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Journal of Neurology|April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesionsXavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
Human Mutation|August 17, 2016
Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited AtaxiasCecilia Marelli, Claire Guissart, Cecile Hubsch, et al.
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology|January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyLaetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Neurology|April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR studyAlvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.
Brain : a Journal of Neurology|June 24, 2020
Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disabilityAnne Kerbrat, Charley Gros, Atef Badji, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Pageof 29